D. V. Kiselev

D. V. Kiselev

Auto-generated profile, based on publicly available information

D. V. Kiselev

Yaroslavl State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2021 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
NSN.N. Spirin
N.N. Spirin
DKD.V. Kiselev
D.V. Kiselev
MKM.S. Karpova
M.S. Karpova
Среди множества разнообразных по локализации и патогенезу болевых синдромов (БС), встречающихся у пациентов с рассеянным склерозом (РС), наибольшее внимание исследователей привлекают нейропатические БС, нередко присутствующие уже на ранних стадиях РС, значительно снижающие качество жизни, нарушающие социальную адаптацию пациентов и плохо поддающиеся терапии. Для пациентов с РС в наибольшей степени характерны центральные нейропатические боли, патогенез которых связан с формированием очагов демиелинизации в ЦНС. Диагностика нейропатических БС при РС основывается главным образом на особенностях клинической картины; данные МРТ головного мозга, нейрофизиологических методов обследования имеют вспомогательное значение. В обзоре рассмотрены современные представления о трех основных видах нейропатических БС при РС: постоянных болях в конечностях, невралгии тройничного нерва и феномене Лермитта. Описаны клинические проявления каждого из синдромов, приведены современные представления о патогенезе, данные об информативности дополнительных методов обследования, проанализированы существующие подходы к консервативному и хирургическому лечению на основе данных рандомизированных исследований.

22 March 2023 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
DKD.V. Kiselev
D.V. Kiselev
VLV.V. Lavrukhin
V.V. Lavrukhin
Acute pain syndromes caused by discogenic lumbosacral radiculopathy and lumboischialgia are not uncommon in clinical practice and characterized by a high risk of becoming chronic. The pathogenetic aspects, features of the clinical picture, existing approaches to conservative treatment of these conditions are analyzed in this paper. Data on the efficacy and safety of a fixed combination of diclofenac and orphenadrine (Neodolpasse) use in the treatment of vertebrogenic pain syndromes based on the NEODOLEX study results are presented, and the authors’ own clinical observations are given. Possible reasons for the high efficacy of Neodolpasse in patients with discogenic radiculopathies and nonspecific back and neck pain are discussed.

21 June 2021 in Therapy
Verified
Journal Article
Closed access
BBBaranova N.S. Baranova
Baranova N.S. Baranova
SSSpirin N.N. Spirin
Spirin N.N. Spirin
OOOvsyannikova L.A. Ovsyannikova
Ovsyannikova L.A. Ovsyannikova
DDDruzhinina T.A. Druzhinina
Druzhinina T.A. Druzhinina
KKKiselev D.V. Kiselev
Kiselev D.V. Kiselev
YRYaroslavl Clinical Hospital No. 2 Of The Yaroslavl Region
Yaroslavl Clinical Hospital No. 2 Of The Yaroslavl Region

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
NSN.N. Spirin
N.N. Spirin
DKD.V. Kiselev
D.V. Kiselev
NBN.S. Baranova
N.S. Baranova
MKM.S. Karpova
M.S. Karpova
Nociceptive and mixed pain syndromes (NMPS) whose pathogenesis is linked with the formation of plaques of demyelination in the CNS are commonly present in patients with multiple sclerosis (MS). NMPS of diverse locations, mechanisms and clinical features significantly worse patients' disability and impair their social adaptation. At the same time, clinicians do not pay enough attention to these syndromes in routine practice. Early diagnosis of NMPS may be important not only for early and appropriate NMPS' therapy and improvement of patients' quality of life, but, possibly, for the diagnosis of the onset or relapsing phase of MS, in cases when NMPS are the symptoms of MS and are the signs of active demyelinating process. This review addresses contemporary views of the main types of NMPS in MS (headaches, musculoskeletal pains, painful tonic spasms, pain with spasticity). Epidemiologic data, pathogenesis, clinical manifestations and diagnostic options of NMPS in patients with MS are described along with current views on MS and NMPS comorbidity theories. Existing approaches to treatment of NMPS based on randomized trials data are analyzed.

1 May 2022 in Neuroscience and Behavioral Physiology
Verified
Journal Article
Closed access
PDF file
NSN. N. Spirin
N. N. Spirin
DKD. V. Kiselev
D. V. Kiselev
MKM. S. Karpova
M. S. Karpova